Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Practical Management of Biosimilar Use in Inflammatory Bowel Disease (IBD): A Global Survey and an International Delphi Consensus
Ferdinando D’Amico, Virginia Solitano, Fernando Magro, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 19, pp. 6350-6350
Open Access | Times Cited: 8

Showing 8 citing articles:

Biological therapy for inflammatory bowel disease: cyclical rather than lifelong treatment?
Christian P. Selinger, Konstantina Rosiou, Marco Vincenzo Lenti
BMJ Open Gastroenterology (2024) Vol. 11, Iss. 1, pp. e001225-e001225
Open Access | Times Cited: 7
Biosimilars in IBD: What Every Clinician Needs to Know
Anthony Angyal, Shubha Bhat
Current Gastroenterology Reports (2024) Vol. 26, Iss. 3, pp. 77-85
Closed Access | Times Cited: 6
TL1A Inhibition in Inflammatory Bowel Disease: A Pipeline Review
Virginia Solitano, María Manuela Estevinho, Federica Ungaro, et al.
BioDrugs (2025)
Closed Access
Unlocking hope: The future of ustekinumab biosimilars in Crohn's disease treatment
Fabrizio Fanizzi, Sarah Bencardino, André Gonçalves, et al.
United European Gastroenterology Journal (2025)
Open Access
Unaware and unpowered: evaluating patient perceptions and preferences of biosimilars in South Korea
Eunjung Choi, Gyeongseon Shin, SeungJin Bae
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Benefits of Biosimilars in the Management of Patients with Inflammatory Bowel Disease: An International Survey
Ferdinando D’Amico, Laurent Peyrin‐Biroulet, Silvio Danese
Journal of Clinical Medicine (2024) Vol. 13, Iss. 11, pp. 3069-3069
Open Access | Times Cited: 3
Raising the bar in ulcerative colitis management
Fabrizio Fanizzi, Mariangela Allocca, Gionata Fiorino, et al.
Therapeutic Advances in Gastroenterology (2024) Vol. 17
Open Access | Times Cited: 1
ARE WE READY FOR MULTIPLE SWITCHES BETWEEN REFERENCE PRODUCTS AND BIOSIMILARS?
Fábio Vieira Teixeira, Laurent Peyrin‐Biroulet, Silvio Danese
Arquivos de Gastroenterologia (2024) Vol. 61
Open Access
Use of Biosimilars to Infliximab During Pregnancy in Women with Inflammatory Bowel Disease: Results from the Pregnancy in Inflammatory Bowel Disease and Neonatal Outcomes (PIANO) Study
Millie D. Long, Sunanda V. Kane, Dawn B. Beaulieu, et al.
Clinical and Translational Gastroenterology (2024)
Open Access
Page 1

Scroll to top